RACHEL KNIGHT: Open Payments
NPI 1720522774 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 29 payments from 8 companies in 2025. Trend: 2023 $1,361 · 2024 $1,249 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $314 |
| CVRx, Inc. | 1 | $91 |
| Novartis Pharmaceuticals Corporation | 5 | $77 |
| Abbott Laboratories | 2 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
Products named: REPATHA, Barostim Neo System, LEQVIO, LifeVest, Kerendia, AVEIR, Assure WCD, TRICLIP.
Industry payments across AZ — which companies pay providers there.
